NICE issues rituximab guidance

The Appraisals Committee of the U.K.'s National Institute for Clinical Excellence released a preliminary appraisal document recommending use of Idec's rituximab

Read the full 215 word article

How to gain access

Continue reading with a
two-week free trial.